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PERCUTANEOUS MANAGEMENT OF PYOGENIC
HEPATIC ABSCESSES
ROLAND ANDERSSON, LILLEMOR FORSBERG*, ESBJORN
HEDERSTROM*, PETER HOCHBERGS* and STIG BENGMARK
Departments of Surgery and Roentgenology*, Lund University, Sweden
Twelve patients (9 men, 3 women) with a mean age of 65 (54-78) years, with pyogenic hepatic abscesses
were managed by percutaneous drainage between 1979 and 1987. Biliary origin was most common (4
patients), followed by hepatic abscesses "as a late postoperative complication (seen in 3 patients) and
hepatic abscesses occurring in association with acute appendicitis (2 patients). The origin was unknovn
in 3 patients. Diagnosis was reached by computed tomography or ultrasonography with a diagnostic
delay of in mean 11 days. Seventeen abscesses were found among the 12 patients. The median abscess
size (maximal diameter) was 7 (1-12) cm. Nine patients were treated with percutaneous drainage with
an indwelling catheter within the abscess cavity for up to 3 weeks, while 3 patients were managed with
percutaneous puncture and aspiration alone. The most commonly isolated organism from the drained
hepatic abscess was E.coli. The course following percutaneous treatment was uneventful, without
mortality and recurrence of the hepatic abscess during follow-up. One patient required surgical drainage
of an additional hepatic abscess.
Percutaneous drainage of hepatic abscesses, independent of origin, thus seems as a safe and reliable
method, which should be considered as the treatment of choice if facilities and knowledge of
percutaneous management are provided.
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INTRODUCTION
The outcome of patients with hepatic abscesses has previously been poor. These
critically ill patients have in general a long period of illness before admission and
also a long delay until correct diagnosis is reached. Pyogenic hepatic abscesses,
especially when multiple, have been associated with mortality rates at or above
25%, despite improvements in diagnosis, antibiotics and surgical therapy-4.
However, during the last decade a marked decrease in mortality has been noted in
association with the introduction of new imaging techniques, such as computed
tomography and ultrasonography, leading to a decrease in diagnostic delay and
making percutaneous drainage possible 5-9. The present study reviews our exper-
ience of percutaneous management of hepatic abscesses with the guidance of
computed tomography or ultrasonography.
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PATIENTS AND METHODS
During the period 1979 to 1987, 12 patients (9 men, 3 women; mean age 65(54-78)
years) with pyogenic hepatic abscesses were treated with percutaneous drainage.
During the same period of time, only one patient was assigned to primary surgery
of an hepatic abscess, due to technical reasons with an interpositioned colonic loop
not rendering the abscess available for percutaneous management. The length of
illness before admission among patients treated percutaneously was in mean 25
days. Symptoms were frequently obscure, merely being signs of sepsis of unknown
origin or malignancy. The hepatic abscesses occurred as late postoperative compli-
cations in 3 patients (following gastric surgery; perforated ulcer in 2, gastric
resection in one), while the etiology among the remaining patients was biliary in 4,
appendicitis in 2 and unknown in 3 patients. The diagnosis was reached by
computed tomography in 4, ultrasonography in 5 or both of these investigations in 3
patients. The delay frown admission until the diagnosis was established was 11
(mean; range 1-21) days. Seventeen hepatic abscesses were diagnosed among the
12 patients: 9 patients had one abscess, 3 patients had 2 and one patient had 3
hepatic abscesses respectively. The median size of the abscess (maximal diameter)
was 7 (range 1-12) cm. Nine patients had abscesses within the right liver lobe, one
in the left and 2 patients had abscesses in both the right and left liver lobes.
Percutaneous management
When a suspected hepatic abscess was found on CT or ultrasonography, the
diagnosis was verified by percutaneous aspiration, then yielding pus. Specimens
were taken for aerobic and anaerobic bacterial culture, as well as for cytology. If a
percutaneous catheter drainage was considered feasible (9 patients), the shortest
way from the skin to the hepatic abscess, using a transperitoneal route, was chosen.
The puncture site was then marked out and local anaesthetics was administered.
The hepatic abscess was punctured with a polyetylene catheter sheathed needle
(trocar catheter drainage set 7-F, MEDA, Sweden, or Ring-McLean sump
drainage set 12-F, 16-F, William Cook, Denmark) under guidance of ultrasound
alone in 4 patients and ultrasound and fluoroscopy in combination in 2 patients.
Computed tomography was used in 2 patients and fluoroscopy alone in one patient.
The sheath was supplied with several sideholes at the tip to facilitate drainage. With
the aid of a guidewire the catheter was coiled within the abscess cavity in order to
reduce the risk of displacement. If needed, the catheter was flushed daily with
saline. Three patients had two catheters inserted. The catheters were removed
when drainage had ceased, the patients’ condition had improved and they were
stable, and when control CT/ultrasonography showed resolution. In 3 patients, the
contents within the abscess was aspirated percutaneously and no catheters were
inserted. All patients received antibiotics.
RESULTS
Bacterial cultures from the drained hepatic abscess were positive in 75% of
instances, with E.coli being the most frequently isolated organism (in 5 patients).
Blood cultures did not show any evidence of bacterial growth, except in one patient
where enterobacter cloacae was cultured.
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In patients with percutaneous catheter drainage, the catheter was left in the
abscess cavity for in median 14 days (range 3-21 days).
All patients survived. Following percutaneous drainage, the patients gradually
improved. No complications attributable to the percutaneous procedure were seen.
One patient, however, where technical reasons contraindicated a repeated percuta-
neous drainage, required surgical drainage of an additional hepatic abscess.
DISCUSSION
Despite the infrequency of pyogenic abscesses, they have constituted a major
problem with high mortality rates. By the guidance of high resolution imaging
techniques it has been possible to perform percutaneous drainage, whereby the
patients can be managed without general anaesthesia and surgery. The drainage
technique has become safer, especially when using ultrasonic punction devices
where the catheter can be seen entering the cavity. In some patients, it can be more
convenient to fill the cavity with contrast medium, using ultrasonic guidance and
thereafter place the catheter under fluoroscopic control. Although the number of
patients treated in this fashion so far is limited, reported mortality rates has been at
or close to zero 6-9. Despite this, it has recently been claimed that surgical drainage
remains the standard 0 and percutaneous drainage could be reserved for high risk
patients .-6. As mortality and morbidity rates following surgical drainage still are
considerable and in the light of the good results reported following percutaneous
management, both in terms of a low morbidity rate and a low recurrence rate,
percutaneous treatment of hepatic abscesses, if available, should be thought of as
the treatment of choice, unless the puncture procedure per se is contraindicated due
to technical reasons. The safety and adequacy of percutaneous drainage of hepatic
abscesses is supported by the present study. Furthermore, site of origin of the
abscess or the occurrence of multiple abscesses within the liver did not contraindi-
cate and did not influence on outcome.
Thus, percutaneous drainage of hepatic abscesses seems as a safe procedure
rendering a favourable outcome, provided that the period of catheter drainage is
long enough.
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